Carregant...
Trifluoperazine versus placebo for schizophrenia
BACKGROUND: Trifluoperazine is a long‐established high potency typical antipsychotic drug used in the treatment of schizophrenia and schizophrenia‐like illnesses. OBJECTIVES: To determine absolute effects of trifluoperazine for schizophrenia and schizophrenia‐like illnesses compared with placebo. To...
Guardat en:
| Publicat a: | Cochrane Database Syst Rev |
|---|---|
| Autors principals: | , , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
John Wiley & Sons, Ltd
2014
|
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6718209/ https://ncbi.nlm.nih.gov/pubmed/24414883 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/14651858.CD010226.pub2 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|